Nicaraven Exerts a Limited Effect on Radiation-Induced Inhibition of Tumor Growth in a Subcutaneous Murine Tumor Model
Radiation Research · 13.09.2023 · 200 (4) · 382-388
DOI: 10.1667/rade-22-00212.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation Research, erschienen am 13.09.2023. Verfasst von Lina Abdelghany und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell Biology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan. Hauptthemen laut MEDLINE: Neoplasms, Radiation Injuries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Nicaraven selectively protects normal tissue from radiation-induced injury. To further develop the clinical application of nicaraven for mitigating the side effects of cancer radiotherapy, we investigated the potential effect of nicaraven administration in radiation-induced inhibition of tumor growth. A subcutaneous tumor model was established in mice by the injection of Lewis lung cancer cells at the back of the chest. X-ray radiation was delivered to the thoracic area and different doses of nicaraven (0, 20, 50, 100 mg/kg) were administrated intraperitoneally pre- or post-irradiation. The tumor size was measured every other day. Mice were euthanized on day 30, and the tumor weight and the levels of cytokines in tumor tissue were measured. Pre- or post-irradiation administration of nicaraven up to a dose of 100 mg/kg did not significantly diminish the radiation-induced inhibition of tumor growth, but post-irradiation administration of 20 and 50 mg/kg nicaraven resulted in relatively lower tumor weight. The levels of IL-1β, IL-6, IL-10, MCP-1, MIP-2a, TGF-β1, VEGF, p53, p21, cyclin D1 and caspase-3 in tumor tissue did not change by nicaraven administration and were not significantly associated with the tumor weights. According to our experimental data, nicaraven will not significantly diminish the radiation-induced inhibition of tumor growth, even with pre-irradiation administration at a high dose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Stem Cell Biology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
- Department of Stem Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
- Department of Radiation Oncology, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Zitieren
APA
Abdelghany, L., Xu, Y., Sekiya, R., Yan, C., Jingu, K., & Li, T. S. (2023). Nicaraven Exerts a Limited Effect on Radiation-Induced Inhibition of Tumor Growth in a Subcutaneous Murine Tumor Model. Radiation Research, 200(4), 382-388. https://doi.org/10.1667/rade-22-00212.1
Vancouver
Abdelghany L, Xu Y, Sekiya R, Yan C, Jingu K, Li TS. Nicaraven Exerts a Limited Effect on Radiation-Induced Inhibition of Tumor Growth in a Subcutaneous Murine Tumor Model. Radiation Research. 2023;200(4):382-388. doi:10.1667/rade-22-00212.1
BibTeX
@article{Abdelghany2023,
author = {Abdelghany, Lina and Xu, Yong and Sekiya, Reiko and Yan, Chen and Jingu, Keiichi and Li, Tao-Sheng},
title = {Nicaraven Exerts a Limited Effect on Radiation-Induced Inhibition of Tumor Growth in a Subcutaneous Murine Tumor Model},
journal = {Radiation Research},
year = {2023},
volume = {200},
number = {4},
pages = {382--388},
doi = {10.1667/rade-22-00212.1}
}
EUVIMED